XYVISION INC
10-Q, 1995-11-14
COMPUTER INTEGRATED SYSTEMS DESIGN
Previous: MEMRY CORP, 10QSB, 1995-11-14
Next: SMITH INTERNATIONAL INC, 10-Q, 1995-11-14




<PAGE>
- ----------------------------------------------------------------------------- 
               UNITED STATES SECURITIES AND EXCHANGE COMMISSION 
                            WASHINGTON, D.C. 20549 
                                  FORM 10-Q 
      [BOX][CHECK] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE 
SECURITIES 
EXCHANGE ACT OF 1934 

                For the quarterly period ended September 30, 1995 
                                      OR 
  [box] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES 
EXCHANGE ACT OF 1934 
                     For the transition period from  to 
                        COMMISSION FILE NUMBER 0-14747 

                                   DELAWARE 

        (STATE OR OTHER JURISDICTION OF INCORPORATION OR ORGANIZATION) 

                                  04-2751102 

                   (I.R.S. EMPLOYER IDENTIFICATION NUMBER) 

                      101 EDGEWATER DRIVE, WAKEFIELD, MA 

                   (ADDRESS OF PRINCIPAL EXECUTIVE OFFICES) 

                                  01880-1291 
                                  (ZIP CODE) 

         Registrant's telephone number including area code (617) 245-4100 
Indicate by check mark whether the registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 
1934 during the preceding 12 months (or for such shorter period that the 
registrant was required to file such reports), and (2) has been subject to 
such filing requirements for the past 90 days. 
                                   Yes  No 
[check] 
Indicate the number of shares outstanding of each of the issuer's classes of 
common stock, as of 
September 30,1995. 

                         COMMON STOCK, $.03 PAR VALUE 

                            (TITLE OF EACH CLASS) 

                                  8,730,959 

                              (NUMBER OF SHARES) 

                                XYVISION, INC. 

                                1           
<PAGE>
                                  FORM 10-Q 
                              TABLE OF CONTENTS 
                                                                          PAGE 

PART I. FINANCIAL INFORMATION 
                         CONSOLIDATED BALANCE SHEETS 
                   AT SEPTEMBER 30, 1995 AND MARCH 31, 1995 

2 Consolidated Statements of Operations 
for the three and six months ended September 30, 1995 and 1994 

3 Consolidated Statements of Cash Flows 
for the six months ended September 30, 1995 and 1994 

4 Notes to Consolidated Financial Statements 

5 Management's Discussion and Analysis of Financial Condition and Results of 
Operations 
8 

PART II. OTHER INFORMATION ............................................11 

                                1           
<PAGE>
                                XYVISION, INC. 
                         CONSOLIDATED BALANCE SHEETS 
                   AT SEPTEMBER 30, 1995 AND MARCH 31, 1995 

<TABLE>
<CAPTION>
<S>                                                                        <C>            <C>
                                                                            (Unaudited) 
                                                                            September 30,    March 31, 
                                                                                 1995         1995 
                                                                           (In thousands) 
                                   ASSETS 

Current assets: 
 Cash and cash equivalents                                                 $      204     $    174 
 Accounts receivable:   Trade, less allowance for doubtful accounts of 
 $752 at June 30, 1995 and $711 at March 31, 1995                               7,697        7,861 
 Inventories                                                                      282          188 
 Other current assets                                                           1,262        1,174 
                                                                           -------------- 
Total current assets                                                            9,445        9,397 

 Property and equipment, net                                                      997        1,218 
 Other assets, net, principally software development costs                      2,682        2,522 
Total assets                                                               $   13,124     $ 13,137 
                   LIABILITIES AND STOCKHOLDERS' DEFICIT 

Current liabilities: 
 Note payable to a shareholder                                             $    2,500     $  1,100 
 Current portion of long-term debt                                              4,051        5,176 
 Accounts payable and accrued expenses                                          3,148        3,665 
 Other current liabilities                                                      2,473        2,656 
Total current liabilities                                                      12,172       12,597 
Long-term debt, less current portion                                            5,435        4,655 
Total liabilities                                                              17,607       17,252 
Commitments and contingencies                                                      --           -- 

Stockholders' deficit: 
 Capital stock: 
  Series preferred stock, $1.00 par value; 2,700,000 shares authorized; no 
 shares issued                                                                     --           -- 
  Series B preferred stock, $1.00 par value; 300,000 shares authorized; 
 222,943 issued at September 30, 1995 and 189,875 issued at March 31, 1995 
 (aggregate liquidation preference of 2,786,788)                                  223          190 
  Common stock, $.03 par value; 20,000,000 shares authorized; 9,296,824 
 issued at September 30, 1995 and 9,218,962 at March 31, 1995                     279          276 
 Additional paid-in capital                                                    41,495       41,177 
 Accumulated deficit                                                          (44,807)     (43,806)    
                                                                               (2,810)      (2,163)    
 Less:   Treasury stock, at cost; 565,865 shares at September 30, 1995 and 
 573,325 shares at March 31, 1995                                               1,436        1,458 
  Receivable from Employee Stock Ownership Plan                                   237          494 
Total stockholders' deficit                                                    (4,483)      (4,115)    
Total liabilities and stockholders' deficit                                $   13,124     $ 13,137 
</TABLE>

  The accompanying notes are an integral part of the consolidated financial 
                                 statements. 

                                2           
<PAGE>
                                XYVISION, INC. 
                     CONSOLIDATED STATEMENT OF OPERATIONS 
        FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 1995 AND 1994 
                    (IN THOUSANDS, EXCEPT PER SHARE DATA) 

<TABLE>
<CAPTION>
<S>                                                      <C>            <C>            <C>            <C>
                                                         Three Months Ended            Six Months Ended 
                                                         September 30,   September    30, September 30,  September    30, 
                                                         1995                 1994     1995                 1994 
                                                         (Unaudited)                   (Unaudited) 
Revenues: 
 Systems                                                 $3,375         $    3,641     $6,988         $    7,430 
 Services                                                2,486               2,313     4,695               4,631 
Total revenues                                           5,861               5,954     11,683             12,061 
Cost of sales: 
 Systems                                                 1,115               1,452     2,678               3,088 
 Service                                                 1,579               1,537     3,099               2,922 
Total cost of sales                                      2,694               2,989     5,777               6,010 
Gross margin                                             3,167               2,965     5,906               6,051 
                                                         --------------                -------------- 

Expenses: 
 Research and development                                781                   738     1,537               1,476 
 Marketing, general and administrative                   2,468               2,026     4,965               4,116 
Total operating expenses                                 3,249               2,764     6,502               5,592 
Income (loss) from operations                            (82)                  201     (596)                 459 

Other expense, net:  Interest income                     3                       3     4                       4 
 Interest expense - third party                          (90)                  (37)       (186)              (94)       
 Interest expense - shareholder                          (105)                 (65)       (182)             (116)       
Total other expense, net                                 (192)                 (99)       (364)             (206)       
                                                         -------------- 
Income (loss) before income taxes and extraordinary item (274)                 102     (960)                 253 
Provision for income taxes                               --                     --       --                   -- 
Income (loss) before extraordinary item                  (274)                 102     (960)                 253 
Extraordinary item:  Gain on exchange of convertible 
 subordinated debentures                                 --                     --       --                   -- 
Net income (loss)                                        (274)                 102     (960)                 253 
Series B Preferred Stock dividends                       22                     --     41                     -- 
Net income (loss) allocable to common stockholders       $(296)         $      102     $(1,001)       $      253 

Earnings per share: 
 Income (loss) per share                                 $(0.03)        $        0.01  $(0.11)        $        0.03 
                                                         ============== ============== ============== ============== 
Weighted average common and common  equivalent shares 
 outstanding                                             8,734               8,980     8,693               8,967 
</TABLE>

  The accompanying notes are an integral part of the consolidated financial 
                                 statements. 

                                3           
<PAGE>
                                XYVISION, INC. 
                    CONSOLIDATED STATEMENTS OF CASH FLOWS 
             FOR THE SIX MONTHS ENDED SEPTEMBER 30, 1995 AND 1994 
                                (IN THOUSANDS) 

<TABLE>
<CAPTION>
<S>                                                                             <C>           <C>
                                                                                Six Months Ended 
                                                                                September 30   September 30, 
                                                                                1995                1994 
                                                                                         (Unaudited) 
Operations: 
Net income (loss)                                                               $(960)        $      253 
Adjustments to reconcile net income to net cash used   for operating 
 activities: 
Depreciation and amortization                                                   1,025              1,052 
Provisions for losses on accounts receivable                                    317                  362 
Loss on disposal of property and equipment                                        --                  -- 
Operating assets and liabilities:  Accounts receivable                          (153)               (342)    
 Retainage                                                                        --                 224 
  Inventories                                                                   (94)                  39 
 Accounts payable and accrued expenses                                          (535)                164 
 Other current liabilities                                                      (177)               (865)    
 Other assets                                                                   (83)                (105)    
                                                                                ------------- -------------- 
Net cash provided from (used for) operations                                    (660)                782 
Investments: 
Additions to property and equipment                                             (192)               (173)    
Proceeds from sale of property and equipment                                      --                  -- 
Additions to customer support spares                                              --                  (1)    
Capitalized software                                                            (737)               (577)    
                                                                                ------------- -------------- 
Net cash used for investments                                                   (929)               (751)    
Financing: Proceeds from line of credit from a shareholder                      2,100                300 
Repayment of line of credit to a shareholder                                    (700)               (700)    
Issuance of common stock                                                        3                     -- 
Payment on 15% Promissory Notes                                                   --                 (63)    
Dividends on preferred stock                                                    (41)                  -- 
Principal loan payment from Employee Stock Ownership Plan                       257                  257 
                                                                                ------------- 
Net cash provided (used for) from financing                                     1,619               (206)    
Net decrease in cash and cash equivalents                                       30                  (175)    
Cash and cash equivalents at the beginning of the period                        174                  312 
                                                                                ------------- -------------- 
Cash and cash equivalents at the end of the period                              $204          $      137 
                                                                                ============= ============== 
Supplemental Information:  Interest paid                                        $120          $       67 
</TABLE>

The accompanying notes are an integral part of the consolidated financial 
                                 statements. 

                                4           
<PAGE>
                                XYVISION, INC. 
                  NOTES TO CONSOLIDATED FINANCIAL STATEMENTS 
                                 (UNAUDITED) 

In the opinion of management, the Company's consolidated financial position 
as of September 30, 1995 and the results of its consolidated operations and 
consolidated cash flows for the interim periods ended September 30, 1995 and 
1994 reflect all adjustments (including normal recurring adjustments) 
necessary to present fairly these financial statements. Certain information 
and footnote disclosures normally included in financial statements prepared 
in accordance with generally accepted accounting principles have been 
condensed or omitted. It is suggested that these financial statements be read 
in conjunction with the Company's Annual Report on Form 10-K for the year 
March 31, 1995. 
The results of consolidated operations for the interim period ended September 
30, 1995 are not necessarily indicative of the results of consolidated 
operations that may be expected for the complete fiscal year. 

Trade receivables do not contain any material amounts collectible over a 
period in excess of one year. Retainage consists of receivables billed under 
retainage provisions of contracts and collectibility is not expected to 
extend over a period of one year. 

Inventories are stated at the lower of cost, determined on a first-in, 
first-out method, or market and consist primarily of finished goods. 

On June 30, 1992, the Company obtained a $2,000,000 line of credit with a 
current investor in the Company. The line, which is payable on demand, is 
secured by substantially all of the assets of the Company and has been used 
for working capital and general business purposes. Interest on the line of 
credit is payable monthly. The Company issued 400,000 shares of common stock 
and a common stock purchase warrant for 100,000 shares of common stock at an 
exercise price of $.50 per share to the investor for no additional 
consideration upon signing of the line of credit. In addition, from September 
30, 1992 through June 30, 1993, the Company granted the investor four 
additional common stock purchase warrants, each covering 100,000 shares of 
common stock. On September 28, 1993, the Company and the investor amended the 
line of credit. Under the terms of this amendment: (i) the amount available 
under the line of credit was increased from $2,000,000 to $2,500,000; (ii) 
the annual interest rate was reduced from 13% to 10%; and (iii) the term of 
the line of credit was extended from June 30, 1994 to June 30, 1995. In 
consideration of such changes, the Company: (i) reduced the exercise price of 
200,000 and 100,000 common stock purchase warrants exercisable by the 
investor from $.50 and $.25 per share, respectively, to $.09 per share (the 
fair market value of the common stock on September 28, 1993); (ii) issued 
200,000 shares of common stock and a warrant to purchase 300,000 shares of 
common stock at an exercise price of $.09 per share to the investor for no 
additional consideration; and (iii) agreed to grant the investor up to eight 
additional warrants, each covering 125,000 shares of common stock at an 
exercise price at the lesser of the fair market value of the common stock on 
the date of issue or $1.00 per share. 
On December 3, 1993, the Company and the investor entered into an additional 
amendment to the line of credit. Under the terms of this amendment, the 
amount available under the line of credit was increased to $3,000,000. In 
consideration of this change, the Company: (i) issued 100,000 shares of 
common stock and a warrant to purchase 500,000 shares of common stock at the 
fair market value of the common stock on December 3, 1993 and (ii) agreed to 
grant the investor up to seven additional common stock purchase warrants 
between December 31, 1993 and June 30, 1995, each covering 200,000 shares of 
common stock at an exercise price at the lesser of the fair market value of 
the common stock on the date of grant or $1.00 per share (these warrants are 
in lieu of the last seven of the warrants referred to in clause (iii) of the 
preceding paragraph). 

   The Company and the investor are currently negotiating an amendment to 
extend the line of credit. The Company expects to complete documentation of 
this amendment in November 1995, but there can be no assurance that it will 
do so. As of September 30, 1995 the Company had an outstanding line of credit 
balance of $2,500,000. As of November 10, 1995, the Company had an 
outstanding line of credit balance of $3,000,000. 

                                5           
<PAGE>
In May 1987, the Company issued $25,000,000 of 6% Convertible Subordinated 
Debentures (the "Debentures") convertible into common stock at a conversion 
price of $22.50 per share. Interest on the Debentures is payable annually (on 
May 5th) and the Debentures may be called by the Company under certain 
conditions. At the beginning of fiscal 1992, the Company had outstanding 
$22,410,000 of these Debentures. This was a significant amount of debt for 
the Company and represented an annual cash interest payment obligation of 
$1,344,600. During fiscal 1992, the Company began a program to restructure 
its financial position, specifically, these Debentures. 

   Since March 10, 1992, the Company has consummated restructuring 
transactions with the holders of a total of $18,700,000 principal amount of 
Debentures. Substantially all of these transactions involved the exchange of 
outstanding Debentures for (i) an unsecured, unsubordinated promissory note 
of Xyvision in a principal amount equal to 30% of the principal amount of the 
Debentures delivered for exchange, bearing interest (payable at maturity) at 
15% per year (compounded annually) and maturing 30 months from issuance and 
(ii) 107,095 shares of common stock of Xyvision per $1,000,000 principal 
amount of Debentures. As of November 10, 1995, a total of $3,710,000 
principal amount of Debentures remained outstanding. Of such Debentures, the 
Company has identified the holders of $1,935,000 principal amount, leaving 
$1,775,000 principal amount of Debentures unidentified. 
During the course of its attempts to restructure the Debentures and negotiate 
transactions with Debentureholders, the Company did not make the interest 
payment due on the Debentures on May 5 of 1992, 1993, 1994 or 1995. Under the 
terms of the Indenture covering the Debentures, the Trustee or the holders of 
not less than 25% of the outstanding principal amount of the debentures have 
the right to accelerate the maturity date of the remaining Debentures. As of 
November 10, 1995, no such acceleration had occurred or been threatened. 
The Company continues to negotiate, in good faith, with as many of the 
remaining Debentureholders as possible. However, despite the progress that 
has been made, the Company can still give no assurance about the outcome of 
the Debenture conversion efforts and does not expect the matter to be 
resolved in the near future. If the Company is unable to enter into exchange 
transactions with the remaining Debentureholders, and such Debentureholders 
seek to pursue legal remedies against the Company, the Company may have to 
seek protection under applicable laws, including the Bankruptcy Code, while 
it develops, analyzes and completes alternative restructuring strategies. 
In addition, as of June 30, 1995 the Company had issued promissory notes in 
an aggregate principal amount of $5,715,000 in connection with the Debenture 
exchange transactions described above, the interest on which accrues at a 
rate of 15% per year and is $2,344,000 payable at maturity. Such 15% 
Promissory Notes in an aggregate principal amount of $4,542,000 were to 
mature on September 30, 1994, and the remainder of these 15% Promissory Notes 
were to mature at various dates between September 30, 1994 and February 28, 
1997. In order to relieve itself of the payment obligations on the Promissory 
Notes, in fiscal 1995 the Company began a program to restructure the 
Promissory Notes. Prior to June 30, 1995, the Company closed exchange 
transactions with 15% Promissory Note holders of an aggregate principal 
amount of $4,647,000 and accrued interest of $1,903,000, in which, in 
exchange for the delivery of a 15% Promissory Note (including all rights to 
receive any interest accrued thereon) for cancellation, the Company issued 
(i) a new Promissory Note that will mature 30 months from the date of 
issuance and bears interest at 4% per annum, (ii) one share of common stock 
for each $10.00 of principal amount of 15% Promissory Note delivered and 
(iii) one share of Series B Preferred Stock for each $10.00 of interest due 
on the 15% Promissory Note delivered. The Series B Preferred Stock accrues a 
cumulative dividend in the amount of $.40 per share per annum, whether or not 
declared and has a liquidation preference of $12.50 per share, plus any 
dividends declared or accrued but unpaid. Each share of Series B Preferred 
Stock is convertible into two shares of common stock, subject to adjustment 
for certain events as defined in the Series B Preferred Stock Agreement. 
Additionally, holders of outstanding shares of Series B Preferred Stock are 
entitled to voting rights equivalent to the rights attributable to the whole 
shares of common stock into which the Series B Preferred are convertible. The 
exchange transaction was completed assuming a fair value of $10 per share of 
Series B Preferred Stock. An independent valuation of the Series B Preferred 
Stock was completed which supported a fair value of $10.00 per share. 
Subsequent to June 30, 1995 and prior to November 10, 1995, the Company 
closed exchange transactions with 15% Promissory Note holders of an 
additional aggregate principal amount of $774,000 and accrued interest of 
$326,000 on substantially the same terms as those described above. The 
Company will seek to restructure the remaining 15% Promissory Notes. 

                                6           
<PAGE>
The Company anticipates that its cash requirements for the remainder of 
fiscal 1996 will be satisfied from its present cash balances, cash flow from 
existing operations, and its credit line, assuming the continued forbearance 
by the Debentureholders and the completion of the amendment to the line of 
credit. The Company can give no assurance on the outcome of the Debenture 
restructuring efforts and does not expect the matter to be resolved in the 
immediate future. Moreover, no assurance can be given as to the ability of 
the Company to satisfy or otherwise discharge its payment obligations under 
the remaining 15% promissory notes issued in connection with the Debenture 
restructuring. The above uncertainties raise substantial doubt about the 
Company's ability to continue as a going concern. The financial statements do 
not include any adjustments relating to the recovery and classifications of 
recorded asset amounts or the amounts and classifications of liabilities that 
might be necessary should the Company be unable to continue as a going 
concern. 
The Company's long term liquidity needs cannot reasonably be determined at 
this time principally because these needs are dependent, in a large part, 
upon the outcome of the Company's ongoing attempts to negotiate an extension 
to its credit line and restructure the remaining outstanding Debentures and 
the ability of the Company to obtain financing to repay or otherwise 
restructure the remaining 15% Promissory Notes. 

The Company's deferred tax assets consist primarily of its net operating loss 
carryforwards. Management has assigned a valuation allowance to fully offset 
the future tax benefits of these deferred tax assets. There has been no 
change to the valuation allowance during the six months ended September 30, 
1995. 

During the first six months of fiscal 1996, the Company supplemented its 
revenue recognition policy to reflect its current business strategy. This 
strategy includes growing a network of domestic and international resellers 
to market its software and services, particularly in its Contex division. 

                                7           
<PAGE>
                                XYVISION, INC. 
  MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF 
                                  OPERATIONS 
             FOR THE SIX MONTHS ENDED SEPTEMBER 30, 1995 AND 1994 

   RESULTS OF OPERATIONS 

   Revenues for the second quarter of fiscal 1996 were $5,861,000, a decrease 
of $93,000, or 2%, from the same quarter of fiscal 1995. Revenues for the 
first six months of fiscal 1996 were $11,683,000, a decrease of $378,000, or 
3%, from the same period of the previous year. In the second quarter of 
fiscal 1996, systems revenues decreased $266,000, or 7% from the same quarter 
of the previous fiscal year. For the first six months of fiscal 1996, systems 
revenues decreased $442,000, or 6% for the comparable period of fiscal 1995. 
These decreases in revenue are primarily the result of decreased hardware 
sales. For the three and six month periods ended September 30, 1995, service 
revenues increased $173,000, or 7%, and $64,000, or 1%, from the comparable 
periods of fiscal 1995 respectively. These increases are primarily due to 
increased international maintenance and training revenues. 

   For the second quarter of fiscal 1996, gross margins increased to 54% of 
revenues from 50% of revenues for the comparable period of fiscal 1995. For 
the first six months of fiscal 1996, gross margins increased to 51% of 
revenues from 50% of revenues for the comparable period of fiscal 1995. 
Systems margins for the second quarter of fiscal 1996 increased to 67% of 
revenues from 60% for the same quarter of fiscal 1995. For the first six 
months of fiscal 1996, systems margins increased to 62% of revenues from 58% 
for the same period of the previous fiscal year. These increases were a 
result of a higher content of software sales. For the second quarter of 
fiscal 1996, service margins increased to 36% of revenues from 34% for the 
same quarter of fiscal 1995. This increase in service margins was the result 
of higher maintenance and training revenues in the European markets and the 
effeciencies associated therewith. For the first six months of fiscal 1996, 
service margins decreased to 34% of revenues from 37% for the same period of 
the previous fiscal year. This decrease in service margins was the result of 
a higher level of fixed costs. 

   Research and development expenses, net of capitalized software development 
costs, were $781,000 and $1,537,000 for the three and six month periods ended 
September 30, 1995. These amounts represent increases of 6% and 4% 
respectively, from the comparable periods of fiscal 1995. Capitalized 
software development costs were $359,000 and $737,000 for second quarter and 
first six months of fiscal 1996, respectively, as compared to $294,000 and 
$577,000 for the same time periods of fiscal 1995. Research and development 
expenses (excluding software development costs) for the second quarter and 
first six months of fiscal 1996 were 13% of revenues as compared to 12% for 
the same periods of fiscal 1995. 

   Marketing, general and administrative expenses were $2,468,000 and 
$4,965,000, or 42% of revenues, for the second quarter and the first six 
months of fiscal 1996, respectively. These are increases from $2,026,000 and 
$4,116,000, which represented 34% of revenues for the comparable periods of 
fiscal 1995. These increases were primarily the result of increased sales and 
marketing spending in the domestic and European markets in order to meet the 
Company's strategy of growing a network of resellers to market its software 
and services. 

   The increase in interest expense for the second quarter and first six 
months of fiscal 1996 were the result of; (1) the impact of the program to 
exchange 15% Promissory Notes for equity securities and 4% Promissory Notes 
described below and in Note 5 to the consolidated financial statements and 
(2) a higher average balance in the credit line described below and in Note 4 
to the consolidated financial statements. The interest expense to maturity of 
the 15% Promissory Notes was recognized when the exchanges occurred. The 
interest expense of the 4% Promissory Notes is recognized ratably over the 
terms of the notes. 

   The Company's deferred tax assets consist of its net operating loss 
carryforwards. Management has assigned a valuation allowance to fully offset 
future tax benefits of these deferred tax assets. There has been no change to 
the valuation allowance for the first six months of fiscal 1996. 

   In the second quarter and first six months of fiscal 1996, as a result of 
the 15% Promissory Note exchange program described below and in Note 5 to the 
consolidated financial statements, the Company declared dividends of $22,000 
and $41,000, respectively, on the Series B Preferred Stock. 

   The Company recorded a net loss allocable to common stockholders of 
$296,000, in the second quarter of fiscal 1996 compared to net income of 
$102,000, for the second quarter of fiscal 1995. For the first six months of 
fiscal 1996, the Company recorded a net loss allocable to common stockholders 
of $1,001,000, compared to net income of $253,000, for the same period a year 
ago. 

   The Company believes that inflation has not had a material effect on its 
results of operations to date. 

                                8           
<PAGE>
LIQUIDITY AND CAPITAL RESOURCES 

   At September 30, 1995, the Company had cash and cash equivalents of 
$204,000, which is an increase of $30,000 from March 31, 1995. During the 
first six months of fiscal 1996, the Company's operating and investment 
activities used $1,589,000 of cash. During the first three months of fiscal 
1996, the Company's operating and investment activities used $1,035,000 of 
cash. 

   The Company has a $3,000,000 line of credit with a stockholder of the 
Company. This credit line, which is payable on demand, is secured by 
substantially all of the assets of the Company and has been used for working 
capital and general business purposes. The credit line currently bears 
interest at a rate of 10% per year, payable monthly. This line of credit 
expired on June 30, 1995. However, the Company and the investor are currently 
negotiating an amendment to extend the line of credit. The Company expects to 
complete documentation of this amendment in November 1995, but there can be 
no assurance that it will do so. As of September 30, 1995 the Company had an 
outstanding line of credit balance of $2,500,000. As of November 10, 1995, 
the Company had an outstanding line of credit balance of $3,000,000. 

   At the beginning of fiscal 1992, the Company had outstanding $22,410,000 
of Debentures. This was a significant amount of debt for the Company and 
represented an annual cash interest payment obligation of $1,344,600. During 
fiscal 1992, the Company began a program to restructure its financial 
position, specifically, these Debentures. 

   Since March 10, 1992, the Company has consummated restructuring 
transactions with the holders of a total of $18,700,000 principal amount of 
Debentures. Substantially all of these transactions involved the exchange of 
outstanding Debentures for (i) an unsecured, unsubordinated promissory note 
of Xyvision in a principal amount equal to 30% of the principal amount of the 
Debentures delivered for exchange, bearing interest (payable at maturity) at 
15% per year (compounded annually) and maturing 30 months from issuance and 
(ii) 107,095 shares of common stock of Xyvision per $1,000,000 principal 
amount of Debentures. As of November 10, 1995, a total of $3,710,000 
principal amount of Debentures remained outstanding. Of such Debentures, the 
Company has identified the holders of $1,935,000 principal amount, leaving 
$1,775,000 principal amount of Debentures unidentified. 

   During the course of its attempts to restructure the Debentures and 
negotiate transactions with Debentureholders, the Company did not make the 
interest payment due on the Debentures on May 5 of 1992, 1993, 1994 or 1995. 
Under the terms of the Indenture covering the Debentures, the Trustee or the 
holders of not less than 25% of the outstanding principal amount of the 
debentures have the right to accelerate the maturity date of the remaining 
Debentures. As of November 10, 1995, no such acceleration had occurred or 
been threatened. 

   The Company continues to negotiate, in good faith, with as many of the 
remaining Debentureholders as possible. However, despite the progress that 
has been made, the Company can still give no assurance about the outcome of 
the Debenture conversion efforts and does not expect the matter to be 
resolved in the near future. If the Company is unable to enter into exchange 
transactions with the remaining Debentureholders, and such Debentureholders 
seek to pursue legal remedies against the Company, the Company may have to 
seek protection under applicable laws, including the Bankruptcy Code, while 
it develops, analyzes and completes alternative restructuring strategies. 

   In addition, as of June 30, 1995 the Company had issued promissory notes 
in an aggregate principal amount of $5,715,000 in connection with the 
Debenture exchange transactions described above, the interest on which 
accrues at a rate of 15% per year and is $2,344,000 payable at maturity. Such 
15% Promissory Notes in an aggregate principal amount of $4,542,000 were to 
mature on September 30, 1994, and the remainder of these 15% Promissory Notes 
were to mature at various dates between September 30, 1994 and February 28, 
1997. In order to relieve itself of the payment obligations on the Promissory 
Notes, in fiscal 1995 the Company began a program to restructure the 
Promissory Notes. Prior to June 30, 1995, the Company closed exchange 
transactions with 15% Promissory Note holders of an aggregate principal 
amount of $4,647,000 and accrued interest of $1,903,000, in which, in 
exchange for the delivery of a 15% Promissory Note (including all rights to 
receive any interest accrued thereon) for cancellation, the Company issued 
(i) a new Promissory Note that will mature 30 months from the date of 
issuance and bears interest at 4% per annum, (ii) one share of common stock 
for each $10.00 of principal amount of 15% Promissory Note delivered and 
(iii) one share of Series B Preferred Stock for each $10.00 of interest due 
on the 15% Promissory Note delivered. The Series B Preferred Stock accrues a 
cumulative dividend in the amount of $.40 per share per annum, whether or not 
declared and has a liquidation reference of $12.50 per share, plus any 
dividends declared or accrued but unpaid. Each share of Series B Preferred 
Stock is convertible into two shares of common stock, subject to adjustment 
for certain events as defined in the Series B Preferred Stock Agreement. 
Additionally, holders of outstanding shares of Series B Preferred Stock are 
entitled to voting rights equivalent to the rights attributable to the whole 
shares of common stock into which the Series B Preferred are convertible. The 

                                9           
<PAGE>
exchange 

                                9           
<PAGE>
transaction was completed assuming a fair value of $10 per share of Series B 
Preferred Stock. An independent valuation of the Series B Preferred Stock was 
completed which supported a fair value of $10.00 per share. 

   Subsequent to June 30, 1995 and prior to November 10, 1995, the Company 
closed exchange transactions with 15% Promissory Note holders of an 
additional aggregate principal amount of $774,000 and accrued interest of 
$326,000 on substantially the same terms as those described above. The 
Company will seek to restructure the remaining 15% Promissory Notes. 

   The Company anticipates that its cash requirements for the remainder of 
fiscal 1996 will be satisfied from its present cash balances, cash flow from 
existing operations, and its credit line, assuming the continued forbearance 
by the Debentureholders and the completion of the amendment to the line of 
credit. The Company can give no assurance on the outcome of the Debenture 
restructuring efforts and does not expect the matter to be resolved in the 
immediate future. Moreover, no assurance can be given as to the ability of 
the Company to satisfy or otherwise discharge its payment obligations under 
the remaining 15% promissory notes issued in connection with the Debenture 
restructuring. The above uncertainties raise substantial doubt about the 
Company's ability to continue as a going concern. The financial statements do 
not include any adjustments relating to the recovery and classifications of 
recorded asset amounts or the amounts and classifications of liabilities that 
might be necessary should the Company be unable to continue as a going 
concern. 

   The Company's long term liquidity needs cannot reasonably be determined at 
this time principally because these needs are dependent, in a large part, 
upon the outcome of the Company's ongoing attempts to negotiate an extension 
to its credit line and to restructure the remaining outstanding Debentures 
and the ability of the Company to obtain financing to repay or otherwise 
restructure the remaining 15% Promissory Notes. 

   For fiscal 1996, Xyvision adjusted its strategy to focus on growing its 
position as a leading supplier of advanced software for document management, 
publishing, and prepress applications by: (i) enhancing and expanding its 
technologies, (ii) focusing on target market segments, (iii) emphasizing 
superior customer support, and (iv) leveraging its global presence. 

   This new strategy will require the Company to invest in the infrastructure 
necessary to capitalize on market opportunities. Such investment may 
negatively impact quarterly operating results during fiscal 1996, especially 
during the first half of the fiscal year. 

   Management believes this investment will increase long-term value to our 
shareholders. While the Company is confident about its future, it can give no 
firm assurance regarding the eventual success of its strategy. 

                               10           
<PAGE>
                          PART II: OTHER INFORMATION 

ITEM 1. LEGAL PROCEEDINGS: NOT APPLICABLE. 

   Item 2. Changes in Securities: Not applicable. 

   Item 3. Defaults upon Senior Securities: Not applicable. 

   Item 4. Submission of Matters to a Vote of Security Holders: The Company 
held its Annual Meeting of Stockholders on September 27, 1995. At this 
meeting the Stockholders of the Company: 
1. Elected Leland S. Kollmorgen (by a vote of 6,703,371 shares in favor and 
57,484 shares withheld) and James McKenney (by a vote of 6,707,761 shares in 
favor and 53,084 shares withheld) to serve as Class III directors of the 
Company until the 1998 Annual Meeting of Stockholders; and 

   2. Ratified the selection of Coopers & Lybrand as the Company's 
independent public accountants for the fiscal year ending March 31, 1995 (by 
a vote of 6,689,767 shares in favor, 65,896 shares against and 5,182 shares 
abstaining; there were no broker non-votes with respect to this matter). 

ITEM 5. OTHER INFORMATION: NOT APPLICABLE. 

ITEM 6. EXHIBITS AND REPORTS ON FORM 8-K: 
NONE. 

                               11           
<PAGE>
                                  SIGNATURES 

   Pursuant to the requirements of the Securities Exchange Act of 1934, the 
Registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized. 

                                  XYVISION, INC. 
- ----------------------------------------------------------------------------- 
                                 (Registrant) 
November 14, 1995 
/s/ Eugene P. Seneta 
- ----------------------------------------------------------------------------- 
Eugene P. Seneta 
Treasurer and Secretary 
(Prinicipal Financial Officer) 

                               12           




<TABLE> <S> <C>

<ARTICLE> 5
<MULTIPLIER> 1,000
       
<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   6-MOS
<FISCAL-YEAR-END>                          MAR-31-1996             MAR-31-1996
<PERIOD-END>                               SEP-30-1995             SEP-30-1995
<CASH>                                             204                     204
<SECURITIES>                                         0                       0
<RECEIVABLES>                                    8,449                   8,449
<ALLOWANCES>                                     (752)                   (752)
<INVENTORY>                                        282                     282
<CURRENT-ASSETS>                                 1,262                   1,262
<PP&E>                                          13,631                  13,631
<DEPRECIATION>                                 (9,952)                 (9,952)
<TOTAL-ASSETS>                                  13,124                  13,124
<CURRENT-LIABILITIES>                           12,172                  12,172
<BONDS>                                          5,435                   5,435
<COMMON>                                       (3,033)                 (3,033)
                                0                       0
                                        223                     223
<OTHER-SE>                                     (1,673)                 (1,673)
<TOTAL-LIABILITY-AND-EQUITY>                    13,124                  13,124
<SALES>                                          5,861                  11,683
<TOTAL-REVENUES>                                 5,861                  11,683
<CGS>                                            2,694                   5,777
<TOTAL-COSTS>                                    2,694                   5,777
<OTHER-EXPENSES>                                 3,106                   6,185
<LOSS-PROVISION>                                   143                     317
<INTEREST-EXPENSE>                                 192                     364
<INCOME-PRETAX>                                  (274)                   (960)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                              (274)                   (960)
<DISCONTINUED>                                       0                       0
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                     (274)                   (960)
<EPS-PRIMARY>                                    (.03)                   (.11)
<EPS-DILUTED>                                    (.03)                   (.11)
        

</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission